Zirconium-89-trastuzumab positron emission tomography as a tool to solve a clinical dilemma in a patient with breast cancer

J Clin Oncol. 2012 Feb 20;30(6):e74-5. doi: 10.1200/JCO.2011.38.0204. Epub 2011 Dec 27.

Authors

Sietske B M Gaykema¹, Adrienne H Brouwers, Sjoerd Hovenga, Marjolijn N Lub-de Hooge, Elizabeth G E de Vries, Caroline P Schröder

Affiliation

¹ Department of Medical Oncology, University Medical Centre Groningen, PO Box 30001, 9700 RB Groningen, the Netherlands.

PMID: 22203768
DOI: 10.1200/JCO.2011.38.0204

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antibodies, Monoclonal, Humanized*
Breast Neoplasms / diagnostic imaging*
Breast Neoplasms / therapy
Combined Modality Therapy
Female
Humans
Liver Neoplasms / diagnostic imaging
Liver Neoplasms / secondary
Lymph Node Excision
Lymphatic Metastasis
Mastectomy
Positron-Emission Tomography / methods*
Radiopharmaceuticals
Sacrum / diagnostic imaging
Spinal Neoplasms / diagnostic imaging
Spinal Neoplasms / secondary

Substances

Antibodies, Monoclonal, Humanized
Radiopharmaceuticals
zirconium-89-trastuzumab